Category: Pharmaceuticals
An Indian multinational pharmaceutical company, Alembic Pharmaceuticals, has recently unveiled that its joint business undertaking Aleor Dermaceuticals has gained approval from the U.S. FDA (Food and Drug Administration) for its ANDA (Abbreviated New Drug Application) Lidocaine Ointment USP, 5%. As per authentic reports, ANDA, the …
Reports confirm that Glenmark Pharmaceuticals Inc., USA has announced that it has obtained a tentative approval from the U.S. Food and Drug Administration (FDA) for Clobetasol Propionate foam. The drug is apparently utilized in treating itching and inflammation caused by various skin conditions such as …
Reports confirm that the U.S. Food and Drug Administration (FDA) on November 21, 2018, has approved a drug from Pfizer which is used in treating a type of blood cancer as a combination therapy in newly diagnosed patients. A spokeswoman from Pfizer revealed that the …
Lupin Limited, a renowned transnational pharmaceutical company headquartered in Mumbai, India, has reportedly announced the launch of its Tetrabenazine tablets in the U.S. Reports cite, the drug is used to treat the involuntary moments that an individual suffering from the Huntington’s disease often experiences. The …
Swiss healthcare conglomerate, Roche AG’s Chinese arm Shanghai Roche Pharmaceuticals Ltd. has recently announced collaboration with biotechnology firm Ascletis BioScience Co., Ltd to expand their partnership on a pegylated interferon treatment (deemed Pegasys) for Hepatitis B and C starting December 2018. As per trusted sources, …
Pharmaceutical giants Fuji Pharma and Alvotech have recently announced that they are collaborating for the development and commercialization of biosimilars in Japan. Under the agreement, Alvotech will be looking after the development and supply of biosimilar assets, while Fuji Pharma will be taking control of …
U.S. biotechnology firm, United Therapeutics Corp. has recently invested $800 million cash upfront to grab rights to Arena Pharmaceuticals’ pulmonary arterial hypertension (PAH) drug, Ralinepag. As per sources, the firm’s executive crew believes that the acquired rights would enable the company to gain huge revenues …
IMV Incorporation, a clinical stage biopharmaceutical company, has reportedly declared the expansion of its clinical program through a Phase 2 basket trial assessing its prime drug, DPX-Survivac, combined with KEYTRUDA (pembrolizumab) and cyclophosphamide, in patients suffering from recurrent or advanced solid tumors. Frederic Ors, Chief …
Silence Therapeutics PLC, a UK based biotechnology firm, has reportedly grabbed headlines by announcing the launch of its first-in-human clinical test, anticipated to kick off in the second half of 2019. For the record, Silence Therapeutics boasts of expertise in RNA interference, which is a …
